HomeTrialNCT06650761
🔬NCT06650761Phase 1ACTIVE NOT RECRUITING

A Phase I Study of CDX-622

Study Summary

This is a study to determine the safety of CDX-622 in healthy participants.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment85 participants
Primary Completion
Lead SponsorCelldex Therapeutics
Data Retrieved2026-04-11 04:09:37.490193+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.